img

Global Anticoagulants Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Anticoagulants Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Anticoagulant drugs (also known as blood thinners) are chemical substances that prevent or reduce coagulation of blood and prolong the blood clotting time.
Anticoagulants Drug report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Anticoagulants Drug market is projected to reach US$ 36990 million in 2034, increasing from US$ 29330 million in 2022, with the CAGR of 3.3% during the period of 2024 to 2034. Demand from Hospital and Clinic are the major drivers for the industry.
Americas is the largest Anticoagulant Drugs market with about 51% market share. Europe is follower, accounting for about 27% market share.The key manufacturers are Bristol-Myers Squibb, Bayer, Pfizer, Johnson & Johnson, Sanofi, Boehringer Ingelheim, Daiichi Sankyo etc. Top 3 companies occupied about 56% market share.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Anticoagulants Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


C. H. Boehringer Sohn (Germany)
Bristol-Myers Squibb (US)
Johnson & Johnson (US)
Pfizer (US)
Daiichi Sankyo (Japan)
Portola Pharmaceuticals (US)
Roche (Switzerland)
Abbott (US)
Siemens (Germany)
Alere (US)
CoaguSense (US)
Segment by Type
Novel Oral Anticoagulants (NOACs)
Warfarin (VKA)
Others

Segment by Application


Hospital
Clinic
Others

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Anticoagulants Drug market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Anticoagulants Drug, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Anticoagulants Drug industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Anticoagulants Drug in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Anticoagulants Drug introduction, etc. Anticoagulants Drug Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Anticoagulants Drug market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Anticoagulants Drug Market Overview
1.1 Anticoagulants Drug Product Overview
1.2 Anticoagulants Drug Market Segment by Type
1.2.1 Novel Oral Anticoagulants (NOACs)
1.2.2 Warfarin (VKA)
1.2.3 Others
1.3 Global Anticoagulants Drug Market Size by Type
1.3.1 Global Anticoagulants Drug Market Size Overview by Type (2018-2034)
1.3.2 Global Anticoagulants Drug Historic Market Size Review by Type (2018-2024)
1.3.3 Global Anticoagulants Drug Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Anticoagulants Drug Sales Breakdown by Type (2018-2024)
1.4.2 Europe Anticoagulants Drug Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Anticoagulants Drug Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Anticoagulants Drug Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Anticoagulants Drug Sales Breakdown by Type (2018-2024)
2 Global Anticoagulants Drug Market Competition by Company
2.1 Global Top Players by Anticoagulants Drug Sales (2018-2024)
2.2 Global Top Players by Anticoagulants Drug Revenue (2018-2024)
2.3 Global Top Players by Anticoagulants Drug Price (2018-2024)
2.4 Global Top Manufacturers Anticoagulants Drug Manufacturing Base Distribution, Sales Area, Product Type
2.5 Anticoagulants Drug Market Competitive Situation and Trends
2.5.1 Anticoagulants Drug Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Anticoagulants Drug Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anticoagulants Drug as of 2022)
2.7 Date of Key Manufacturers Enter into Anticoagulants Drug Market
2.8 Key Manufacturers Anticoagulants Drug Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Anticoagulants Drug Status and Outlook by Region
3.1 Global Anticoagulants Drug Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Anticoagulants Drug Historic Market Size by Region
3.2.1 Global Anticoagulants Drug Sales in Volume by Region (2018-2024)
3.2.2 Global Anticoagulants Drug Sales in Value by Region (2018-2024)
3.2.3 Global Anticoagulants Drug Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Anticoagulants Drug Forecasted Market Size by Region
3.3.1 Global Anticoagulants Drug Sales in Volume by Region (2024-2034)
3.3.2 Global Anticoagulants Drug Sales in Value by Region (2024-2034)
3.3.3 Global Anticoagulants Drug Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Anticoagulants Drug by Application
4.1 Anticoagulants Drug Market Segment by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Others
4.2 Global Anticoagulants Drug Market Size by Application
4.2.1 Global Anticoagulants Drug Market Size Overview by Application (2018-2034)
4.2.2 Global Anticoagulants Drug Historic Market Size Review by Application (2018-2024)
4.2.3 Global Anticoagulants Drug Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Anticoagulants Drug Sales Breakdown by Application (2018-2024)
4.3.2 Europe Anticoagulants Drug Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Anticoagulants Drug Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Anticoagulants Drug Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Anticoagulants Drug Sales Breakdown by Application (2018-2024)
5 North America Anticoagulants Drug by Country
5.1 North America Anticoagulants Drug Historic Market Size by Country
5.1.1 North America Anticoagulants Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Anticoagulants Drug Sales in Volume by Country (2018-2024)
5.1.3 North America Anticoagulants Drug Sales in Value by Country (2018-2024)
5.2 North America Anticoagulants Drug Forecasted Market Size by Country
5.2.1 North America Anticoagulants Drug Sales in Volume by Country (2024-2034)
5.2.2 North America Anticoagulants Drug Sales in Value by Country (2024-2034)
6 Europe Anticoagulants Drug by Country
6.1 Europe Anticoagulants Drug Historic Market Size by Country
6.1.1 Europe Anticoagulants Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Anticoagulants Drug Sales in Volume by Country (2018-2024)
6.1.3 Europe Anticoagulants Drug Sales in Value by Country (2018-2024)
6.2 Europe Anticoagulants Drug Forecasted Market Size by Country
6.2.1 Europe Anticoagulants Drug Sales in Volume by Country (2024-2034)
6.2.2 Europe Anticoagulants Drug Sales in Value by Country (2024-2034)
7 Asia-Pacific Anticoagulants Drug by Region
7.1 Asia-Pacific Anticoagulants Drug Historic Market Size by Region
7.1.1 Asia-Pacific Anticoagulants Drug Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Anticoagulants Drug Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Anticoagulants Drug Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Anticoagulants Drug Forecasted Market Size by Region
7.2.1 Asia-Pacific Anticoagulants Drug Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Anticoagulants Drug Sales in Value by Region (2024-2034)
8 Latin America Anticoagulants Drug by Country
8.1 Latin America Anticoagulants Drug Historic Market Size by Country
8.1.1 Latin America Anticoagulants Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Anticoagulants Drug Sales in Volume by Country (2018-2024)
8.1.3 Latin America Anticoagulants Drug Sales in Value by Country (2018-2024)
8.2 Latin America Anticoagulants Drug Forecasted Market Size by Country
8.2.1 Latin America Anticoagulants Drug Sales in Volume by Country (2024-2034)
8.2.2 Latin America Anticoagulants Drug Sales in Value by Country (2024-2034)
9 Middle East and Africa Anticoagulants Drug by Country
9.1 Middle East and Africa Anticoagulants Drug Historic Market Size by Country
9.1.1 Middle East and Africa Anticoagulants Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Anticoagulants Drug Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Anticoagulants Drug Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Anticoagulants Drug Forecasted Market Size by Country
9.2.1 Middle East and Africa Anticoagulants Drug Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Anticoagulants Drug Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 C. H. Boehringer Sohn (Germany)
10.1.1 C. H. Boehringer Sohn (Germany) Company Information
10.1.2 C. H. Boehringer Sohn (Germany) Introduction and Business Overview
10.1.3 C. H. Boehringer Sohn (Germany) Anticoagulants Drug Sales, Revenue and Gross Margin (2018-2024)
10.1.4 C. H. Boehringer Sohn (Germany) Anticoagulants Drug Products Offered
10.1.5 C. H. Boehringer Sohn (Germany) Recent Development
10.2 Bristol-Myers Squibb (US)
10.2.1 Bristol-Myers Squibb (US) Company Information
10.2.2 Bristol-Myers Squibb (US) Introduction and Business Overview
10.2.3 Bristol-Myers Squibb (US) Anticoagulants Drug Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Bristol-Myers Squibb (US) Anticoagulants Drug Products Offered
10.2.5 Bristol-Myers Squibb (US) Recent Development
10.3 Johnson & Johnson (US)
10.3.1 Johnson & Johnson (US) Company Information
10.3.2 Johnson & Johnson (US) Introduction and Business Overview
10.3.3 Johnson & Johnson (US) Anticoagulants Drug Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Johnson & Johnson (US) Anticoagulants Drug Products Offered
10.3.5 Johnson & Johnson (US) Recent Development
10.4 Pfizer (US)
10.4.1 Pfizer (US) Company Information
10.4.2 Pfizer (US) Introduction and Business Overview
10.4.3 Pfizer (US) Anticoagulants Drug Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Pfizer (US) Anticoagulants Drug Products Offered
10.4.5 Pfizer (US) Recent Development
10.5 Daiichi Sankyo (Japan)
10.5.1 Daiichi Sankyo (Japan) Company Information
10.5.2 Daiichi Sankyo (Japan) Introduction and Business Overview
10.5.3 Daiichi Sankyo (Japan) Anticoagulants Drug Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Daiichi Sankyo (Japan) Anticoagulants Drug Products Offered
10.5.5 Daiichi Sankyo (Japan) Recent Development
10.6 Portola Pharmaceuticals (US)
10.6.1 Portola Pharmaceuticals (US) Company Information
10.6.2 Portola Pharmaceuticals (US) Introduction and Business Overview
10.6.3 Portola Pharmaceuticals (US) Anticoagulants Drug Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Portola Pharmaceuticals (US) Anticoagulants Drug Products Offered
10.6.5 Portola Pharmaceuticals (US) Recent Development
10.7 Roche (Switzerland)
10.7.1 Roche (Switzerland) Company Information
10.7.2 Roche (Switzerland) Introduction and Business Overview
10.7.3 Roche (Switzerland) Anticoagulants Drug Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Roche (Switzerland) Anticoagulants Drug Products Offered
10.7.5 Roche (Switzerland) Recent Development
10.8 Abbott (US)
10.8.1 Abbott (US) Company Information
10.8.2 Abbott (US) Introduction and Business Overview
10.8.3 Abbott (US) Anticoagulants Drug Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Abbott (US) Anticoagulants Drug Products Offered
10.8.5 Abbott (US) Recent Development
10.9 Siemens (Germany)
10.9.1 Siemens (Germany) Company Information
10.9.2 Siemens (Germany) Introduction and Business Overview
10.9.3 Siemens (Germany) Anticoagulants Drug Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Siemens (Germany) Anticoagulants Drug Products Offered
10.9.5 Siemens (Germany) Recent Development
10.10 Alere (US)
10.10.1 Alere (US) Company Information
10.10.2 Alere (US) Introduction and Business Overview
10.10.3 Alere (US) Anticoagulants Drug Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Alere (US) Anticoagulants Drug Products Offered
10.10.5 Alere (US) Recent Development
10.11 CoaguSense (US)
10.11.1 CoaguSense (US) Company Information
10.11.2 CoaguSense (US) Introduction and Business Overview
10.11.3 CoaguSense (US) Anticoagulants Drug Sales, Revenue and Gross Margin (2018-2024)
10.11.4 CoaguSense (US) Anticoagulants Drug Products Offered
10.11.5 CoaguSense (US) Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Anticoagulants Drug Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Anticoagulants Drug Industrial Chain Analysis
11.4 Anticoagulants Drug Market Dynamics
11.4.1 Anticoagulants Drug Industry Trends
11.4.2 Anticoagulants Drug Market Drivers
11.4.3 Anticoagulants Drug Market Challenges
11.4.4 Anticoagulants Drug Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Anticoagulants Drug Distributors
12.3 Anticoagulants Drug Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Novel Oral Anticoagulants (NOACs)
Table 2. Major Company of Warfarin (VKA)
Table 3. Major Company of Others
Table 4. Global Anticoagulants Drug Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 5. Global Anticoagulants Drug Sales by Type (2018-2024) & (K Pcs)
Table 6. Global Anticoagulants Drug Sales Market Share in Volume by Type (2018-2024)
Table 7. Global Anticoagulants Drug Sales by Type (2018-2024) & (US& Million)
Table 8. Global Anticoagulants Drug Market Share in Value by Type (2018-2024)
Table 9. Global Anticoagulants Drug Price by Type (2018-2024) & (USD/Pcs)
Table 10. Global Anticoagulants Drug Sales by Type (2024-2034) & (K Pcs)
Table 11. Global Anticoagulants Drug Sales Market Share in Volume by Type (2024-2034)
Table 12. Global Anticoagulants Drug Sales by Type (2024-2034) & (US$ Million)
Table 13. Global Anticoagulants Drug Sales Market Share in Value by Type (2024-2034)
Table 14. Global Anticoagulants Drug Price by Type (2024-2034) & (USD/Pcs)
Table 15. North America Anticoagulants Drug Sales by Type (2018-2024) & (K Pcs)
Table 16. North America Anticoagulants Drug Sales by Type (2018-2024) & (US$ Million)
Table 17. Europe Anticoagulants Drug Sales (K Pcs) by Type (2018-2024)
Table 18. Europe Anticoagulants Drug Sales by Type (2018-2024) & (US$ Million)
Table 19. Asia-Pacific Anticoagulants Drug Sales (K Pcs) by Type (2018-2024)
Table 20. Asia-Pacific Anticoagulants Drug Sales by Type (2018-2024) & (US$ Million)
Table 21. Latin America Anticoagulants Drug Sales (K Pcs) by Type (2018-2024)
Table 22. Latin America Anticoagulants Drug Sales by Type (2018-2024) & (US$ Million)
Table 23. Middle East and Africa Anticoagulants Drug Sales (K Pcs) by Type (2018-2024)
Table 24. Middle East and Africa Anticoagulants Drug Sales by Type (2018-2024) & (US$ Million)
Table 25. Global Anticoagulants Drug Sales by Company (2018-2024) & (K Pcs)
Table 26. Global Anticoagulants Drug Sales Share by Company (2018-2024)
Table 27. Global Anticoagulants Drug Revenue by Company (2018-2024) & (US$ Million)
Table 28. Global Anticoagulants Drug Revenue Share by Company (2018-2024)
Table 29. Global Market Anticoagulants Drug Price by Company (2018-2024) & (USD/Pcs)
Table 30. Global Anticoagulants Drug Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 31. Global Anticoagulants Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anticoagulants Drug as of 2022)
Table 33. Date of Key Manufacturers Enter into Anticoagulants Drug Market
Table 34. Key Manufacturers Anticoagulants Drug Product Type
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Anticoagulants Drug Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 37. Global Anticoagulants Drug Sales by Region (2018-2024) & (K Pcs)
Table 38. Global Anticoagulants Drug Sales Market Share in Volume by Region (2018-2024)
Table 39. Global Anticoagulants Drug Sales by Region (2018-2024) & (US$ Million)
Table 40. Global Anticoagulants Drug Sales Market Share in Value by Region (2018-2024)
Table 41. Global Anticoagulants Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 42. Global Anticoagulants Drug Sales by Region (2024-2034) & (K Pcs)
Table 43. Global Anticoagulants Drug Sales Market Share in Volume by Region (2024-2034)
Table 44. Global Anticoagulants Drug Sales by Region (2024-2034) & (US$ Million)
Table 45. Global Anticoagulants Drug Sales Market Share in Value by Region (2024-2034)
Table 46. Global Anticoagulants Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2024-2034)
Table 47. Global Anticoagulants Drug Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 48. Global Anticoagulants Drug Sales by Application (2018-2024) & (K Pcs)
Table 49. Global Anticoagulants Drug Sales Market Share in Volume by Application (2018-2024)
Table 50. Global Anticoagulants Drug Sales by Application (2018-2024) & (US$ Million)
Table 51. Global Anticoagulants Drug Sales Market Share in Value by Application (2018-2024)
Table 52. Global Anticoagulants Drug Price by Application (2018-2024) & (USD/Pcs)
Table 53. Global Anticoagulants Drug Sales by Application (2024-2034) & (K Pcs)
Table 54. Global Anticoagulants Drug Sales Market Share in Volume by Application (2024-2034)
Table 55. Global Anticoagulants Drug Sales by Application (2024-2034) & (US$ Million)
Table 56. Global Anticoagulants Drug Sales Market Share in Value by Application (2024-2034)
Table 57. Global Anticoagulants Drug Price by Application (2024-2034) & (USD/Pcs)
Table 58. North America Anticoagulants Drug Sales by Application (2018-2024) (K Pcs)
Table 59. North America Anticoagulants Drug Sales by Application (2018-2024) & (US$ Million)
Table 60. Europe Anticoagulants Drug Sales by Application (2018-2024) (K Pcs)
Table 61. Europe Anticoagulants Drug Sales by Application (2018-2024) & (US$ Million)
Table 62. Asia-Pacific Anticoagulants Drug Sales by Application (2018-2024) (K Pcs)
Table 63. Asia-Pacific Anticoagulants Drug Sales by Application (2018-2024) & (US$ Million)
Table 64. Latin America Anticoagulants Drug Sales by Application (2018-2024) (K Pcs)
Table 65. Latin America Anticoagulants Drug Sales by Application (2018-2024) & (US$ Million)
Table 66. Middle East and Africa Anticoagulants Drug Sales by Application (2018-2024) (K Pcs)
Table 67. Middle East and Africa Anticoagulants Drug Sales by Application (2018-2024) & (US$ Million)
Table 68. North America Anticoagulants Drug Sales by Country (2018-2024) & (K Pcs)
Table 69. North America Anticoagulants Drug Sales Market Share in Volume by Country (2018-2024)
Table 70. North America Anticoagulants Drug Sales by Country (2018-2024) & (US$ Million)
Table 71. North America Anticoagulants Drug Sales Market Share in Value by Country (2018-2024)
Table 72. North America Anticoagulants Drug Sales by Country (2024-2034) & (K Pcs)
Table 73. North America Anticoagulants Drug Sales Market Share in Volume by Country (2024-2034)
Table 74. North America Anticoagulants Drug Sales by Country (2024-2034) & (US$ Million)
Table 75. North America Anticoagulants Drug Sales Market Share in Value by Country (2024-2034)
Table 76. Europe Anticoagulants Drug Sales by Country (2018-2024) & (K Pcs)
Table 77. Europe Anticoagulants Drug Sales Market Share in Volume by Country (2018-2024)
Table 78. Europe Anticoagulants Drug Sales by Country (2018-2024) & (US$ Million)
Table 79. Europe Anticoagulants Drug Sales Market Share in Value by Country (2018-2024)
Table 80. Europe Anticoagulants Drug Sales by Country (2024-2034) & (K Pcs)
Table 81. Europe Anticoagulants Drug Sales Market Share in Volume by Country (2024-2034)
Table 82. Europe Anticoagulants Drug Sales by Country (2024-2034) & (US$ Million)
Table 83. Europe Anticoagulants Drug Sales Market Share in Value by Country (2024-2034)
Table 84. Asia-Pacific Anticoagulants Drug Sales by Region (2018-2024) & (K Pcs)
Table 85. Asia-Pacific Anticoagulants Drug Sales Market Share in Volume by Region (2018-2024)
Table 86. Asia-Pacific Anticoagulants Drug Sales by Region (2018-2024) & (US$ Million)
Table 87. Asia-Pacific Anticoagulants Drug Sales Market Share in Value by Region (2018-2024)
Table 88. Asia-Pacific Anticoagulants Drug Sales by Region (2024-2034) & (K Pcs)
Table 89. Asia-Pacific Anticoagulants Drug Sales Market Share in Volume by Region (2024-2034)
Table 90. Asia-Pacific Anticoagulants Drug Sales by Region (2024-2034) & (US$ Million)
Table 91. Asia-Pacific Anticoagulants Drug Sales Market Share in Value by Region (2024-2034)
Table 92. Latin America Anticoagulants Drug Sales by Country (2018-2024) & (K Pcs)
Table 93. Latin America Anticoagulants Drug Sales Market Share in Volume by Country (2018-2024)
Table 94. Latin America Anticoagulants Drug Sales by Country (2018-2024) & (US$ Million)
Table 95. Latin America Anticoagulants Drug Sales Market Share in Value by Country (2018-2024)
Table 96. Latin America Anticoagulants Drug Sales by Country (2024-2034) & (K Pcs)
Table 97. Latin America Anticoagulants Drug Sales Market Share in Volume by Country (2024-2034)
Table 98. Latin America Anticoagulants Drug Sales by Country (2024-2034) & (US$ Million)
Table 99. Latin America Anticoagulants Drug Sales Market Share in Value by Country (2024-2034)
Table 100. Middle East and Africa Anticoagulants Drug Sales by Country (2018-2024) & (K Pcs)
Table 101. Middle East and Africa Anticoagulants Drug Sales Market Share in Volume by Country (2018-2024)
Table 102. Middle East and Africa Anticoagulants Drug Sales by Country (2018-2024) & (US$ Million)
Table 103. Middle East and Africa Anticoagulants Drug Sales Market Share in Value by Country (2018-2024)
Table 104. Middle East and Africa Anticoagulants Drug Sales by Country (2024-2034) & (K Pcs)
Table 105. Middle East and Africa Anticoagulants Drug Sales Market Share in Volume by Country (2024-2034)
Table 106. Middle East and Africa Anticoagulants Drug Sales by Country (2024-2034) & (US$ Million)
Table 107. Middle East and Africa Anticoagulants Drug Sales Market Share in Value by Country (2024-2034)
Table 108. C. H. Boehringer Sohn (Germany) Company Information
Table 109. C. H. Boehringer Sohn (Germany) Introduction and Business Overview
Table 110. C. H. Boehringer Sohn (Germany) Anticoagulants Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 111. C. H. Boehringer Sohn (Germany) Anticoagulants Drug Product
Table 112. C. H. Boehringer Sohn (Germany) Recent Development
Table 113. Bristol-Myers Squibb (US) Company Information
Table 114. Bristol-Myers Squibb (US) Introduction and Business Overview
Table 115. Bristol-Myers Squibb (US) Anticoagulants Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 116. Bristol-Myers Squibb (US) Anticoagulants Drug Product
Table 117. Bristol-Myers Squibb (US) Recent Development
Table 118. Johnson & Johnson (US) Company Information
Table 119. Johnson & Johnson (US) Introduction and Business Overview
Table 120. Johnson & Johnson (US) Anticoagulants Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 121. Johnson & Johnson (US) Anticoagulants Drug Product
Table 122. Johnson & Johnson (US) Recent Development
Table 123. Pfizer (US) Company Information
Table 124. Pfizer (US) Introduction and Business Overview
Table 125. Pfizer (US) Anticoagulants Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 126. Pfizer (US) Anticoagulants Drug Product
Table 127. Pfizer (US) Recent Development
Table 128. Daiichi Sankyo (Japan) Company Information
Table 129. Daiichi Sankyo (Japan) Introduction and Business Overview
Table 130. Daiichi Sankyo (Japan) Anticoagulants Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 131. Daiichi Sankyo (Japan) Anticoagulants Drug Product
Table 132. Daiichi Sankyo (Japan) Recent Development
Table 133. Portola Pharmaceuticals (US) Company Information
Table 134. Portola Pharmaceuticals (US) Introduction and Business Overview
Table 135. Portola Pharmaceuticals (US) Anticoagulants Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 136. Portola Pharmaceuticals (US) Anticoagulants Drug Product
Table 137. Portola Pharmaceuticals (US) Recent Development
Table 138. Roche (Switzerland) Company Information
Table 139. Roche (Switzerland) Introduction and Business Overview
Table 140. Roche (Switzerland) Anticoagulants Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 141. Roche (Switzerland) Anticoagulants Drug Product
Table 142. Roche (Switzerland) Recent Development
Table 143. Abbott (US) Company Information
Table 144. Abbott (US) Introduction and Business Overview
Table 145. Abbott (US) Anticoagulants Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 146. Abbott (US) Anticoagulants Drug Product
Table 147. Abbott (US) Recent Development
Table 148. Siemens (Germany) Company Information
Table 149. Siemens (Germany) Introduction and Business Overview
Table 150. Siemens (Germany) Anticoagulants Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 151. Siemens (Germany) Anticoagulants Drug Product
Table 152. Siemens (Germany) Recent Development
Table 153. Alere (US) Company Information
Table 154. Alere (US) Introduction and Business Overview
Table 155. Alere (US) Anticoagulants Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 156. Alere (US) Anticoagulants Drug Product
Table 157. Alere (US) Recent Development
Table 158. CoaguSense (US) Company Information
Table 159. CoaguSense (US) Introduction and Business Overview
Table 160. CoaguSense (US) Anticoagulants Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 161. CoaguSense (US) Anticoagulants Drug Product
Table 162. CoaguSense (US) Recent Development
Table 163. Key Raw Materials Lists
Table 164. Raw Materials Key Suppliers Lists
Table 165. Anticoagulants Drug Market Trends
Table 166. Anticoagulants Drug Market Drivers
Table 167. Anticoagulants Drug Market Challenges
Table 168. Anticoagulants Drug Market Restraints
Table 169. Anticoagulants Drug Distributors List
Table 170. Anticoagulants Drug Downstream Customers
Table 171. Research Programs/Design for This Report
Table 172. Key Data Information from Secondary Sources
Table 173. Key Data Information from Primary Sources
List of Figures
Figure 1. Anticoagulants Drug Product Picture
Figure 2. Global Anticoagulants Drug Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Anticoagulants Drug Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Anticoagulants Drug Sales Status and Outlook (2018-2034) & (K Pcs)
Figure 5. Product Picture of Novel Oral Anticoagulants (NOACs)
Figure 6. Global Novel Oral Anticoagulants (NOACs) Sales YoY Growth (2018-2034) & (K Pcs)
Figure 7. Product Picture of Warfarin (VKA)
Figure 8. Global Warfarin (VKA) Sales YoY Growth (2018-2034) & (K Pcs)
Figure 9. Product Picture of Others
Figure 10. Global Others Sales YoY Growth (2018-2034) & (K Pcs)
Figure 11. Global Anticoagulants Drug Sales by Type (2018-2034) & (US$ Million)
Figure 12. Global Anticoagulants Drug Sales Market Share by Type in 2022 & 2034
Figure 13. North America Anticoagulants Drug Sales Market Share in Volume by Type in 2022
Figure 14. North America Anticoagulants Drug Sales Market Share in Value by Type in 2022
Figure 15. Europe Anticoagulants Drug Sales Market Share in Volume by Type in 2022
Figure 16. Europe Anticoagulants Drug Sales Market Share in Value by Type in 2022
Figure 17. Asia-Pacific Anticoagulants Drug Sales Market Share in Volume by Type in 2022
Figure 18. Asia-Pacific Anticoagulants Drug Sales Market Share in Value by Type in 2022
Figure 19. Latin America Anticoagulants Drug Sales Market Share in Volume by Type in 2022
Figure 20. Latin America Anticoagulants Drug Sales Market Share in Value by Type in 2022
Figure 21. Middle East and Africa Anticoagulants Drug Sales Market Share in Volume by Type in 2022
Figure 22. Middle East and Africa Anticoagulants Drug Sales Market Share in Value by Type in 2022
Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Anticoagulants Drug Sales in 2022
Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Anticoagulants Drug Revenue in 2022
Figure 25. Anticoagulants Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 26. Product Picture of Hospital
Figure 27. Global Hospital Sales YoY Growth (2018-2034) & (K Pcs)
Figure 28. Product Picture of Clinic
Figure 29. Global Clinic Sales YoY Growth (2018-2034) & (K Pcs)
Figure 30. Product Picture of Others
Figure 31. Global Others Sales YoY Growth (2018-2034) & (K Pcs)
Figure 32. Global Anticoagulants Drug Sales by Application (2018-2034) & (US$ Million)
Figure 33. Global Anticoagulants Drug Sales Market Share by Application in 2022 & 2034
Figure 34. North America Anticoagulants Drug Sales Market Share in Volume by Application in 2022
Figure 35. North America Anticoagulants Drug Sales Market Share in Value by Application in 2022
Figure 36. Europe Anticoagulants Drug Sales Market Share in Volume by Application in 2022
Figure 37. Europe Anticoagulants Drug Sales Market Share in Value by Application in 2022
Figure 38. Asia-Pacific Anticoagulants Drug Sales Market Share in Volume by Application in 2022
Figure 39. Asia-Pacific Anticoagulants Drug Sales Market Share in Value by Application in 2022
Figure 40. Latin America Anticoagulants Drug Sales Market Share in Volume by Application in 2022
Figure 41. Latin America Anticoagulants Drug Sales Market Share in Value by Application in 2022
Figure 42. Middle East and Africa Anticoagulants Drug Sales Market Share in Value by Application in 2022
Figure 43. Key Raw Materials Price
Figure 44. Anticoagulants Drug Manufacturing Cost Structure
Figure 45. Anticoagulants Drug Industrial Chain Analysis
Figure 46. Channels of Distribution
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries